What is Revelation Biosciences Inc (REVB) stock price today?

Revelation Biosciences Inc (REVB) currently trades at $1.12 per share. The stock has a market capitalization of $4.32M and a P/E ratio of —x.

Is REVB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Revelation Biosciences Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

REVB

Revelation Biosciences Inc

NASDAQ: REVB · HEALTHCARE · BIOTECHNOLOGY

$1.12

-0.88% today

Updated 2026-05-01

Market cap

$4.32M

P/E ratio

—

P/S ratio

2.88x

EPS (TTM)

$-23.95

Dividend yield

—

52W range

$1 – $40

Volume

0.1M

Market cap

$4.32M

P/E ratio

—

P/S ratio

2.88x

EPS (TTM)

$-23.95

Dividend yield

—

52W range

$1 – $40

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$19.25

+1618.75%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-1.97M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-10.83M	$-120254.00	$-15.04M	$-8.91M	$-2.51M
EPS	—	—	—	—	$-23.95
Free cash flow	$-11.22M	$-7.29M	$-18.34M	$-8.27M	$-1.97M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
REVB	$4.32M	31	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-41.61%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-26.29%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.35%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Revelation Biosciences Inc trades at $1.12. Our Smart Value Score of 31/100 indicates the stock is weak.

Frequently asked questions

What is Revelation Biosciences Inc's stock price?

Revelation Biosciences Inc (REVB) trades at $1.12.

Is Revelation Biosciences Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Revelation Biosciences Inc (REVB)?

The analyst target price is $19.25, representing +1618.7% upside from the current price of $1.12.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.88x

ROE-131.40%

Beta-0.17

50D MA$1.24

200D MA$4.80

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

REVB vs LLY →REVB vs JNJ →REVB vs ABBV →Stock screener →